1 Reason Rocket Lab Stock Could Be a Monster Winner
Rocket Lab shares have shed nearly all their 2026 gains despite a record backlog and a deal that could fundamentally transform the company's revenue profile, and the gap between where the stock sits today and where our model puts it…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Rocket Lab (NASDAQ:RKLB | RKLB Price Prediction) has become one of the most watched space stocks on the market, and our proprietary model sees room for a sizable move higher.
The one reason it could turn into a monster winner: a launch-plus-systems-plus-applications flywheel that few competitors can match, now backed by a $2.36 billion backlog and a pending transformative acquisition.
| Metric | Value |
|---|---|
| Current Price | $63.92 |
| 24/7 Wall St. Price Target | $123.10 |
| Upside | 92.59% |
| Recommendation | BUY |
| Confidence Level | 50% |
Our 24/7 Wall St. price target for Rocket Lab is $123.10 over the next 12 months, implying meaningful upside. Confidence sits at medium, appropriate for a pre-profit growth story with a high-beta profile.

A Backlog-Driven Reset After a Volatile Summer
RKLB has been volatile. Shares hit $151 earlier in the trading year before pulling back to the low $60s, and are now down 8.37% year to date and 6.39% over the past week. Over five years, the stock is up 530.37%.
Q2 2026 was a record quarter. Revenue grew 62% year over year to $234.07 million, beating consensus by 1.35%. GAAP EPS of -$0.08 came in just below the -$0.0767 estimate, weighed down by $8.576 million in acquisition-related transaction costs.
Non-GAAP gross margin expanded to 41.5%, and management guided Q3 revenue to $250 million to $265 million. CEO Peter Beck noted “more than a billion dollars in new contracts across launch and space systems already entered into in Q3.”
Why Bulls See a Breakout Ahead
The bull thesis: Rocket Lab is becoming a self-launching, tier-one space power. The Iridium acquisition adds a constellation of 66 satellites, 2.5 million subscribers, and roughly $870 million in annual recurring revenue. Neutron is tracking to Q4 2026 delivery to the pad, with more than 400 hot fires completed.
Defense tailwinds are enormous, with the FY2027 Golden Dome program requesting $17.9 billion and the U.S. Space Force budget climbing to $71.2 billion. If Neutron flies cleanly and Iridium closes, the bull case points to $156.54, or roughly 144.91% upside.
Risks Worth Watching
The bear case is real. RKLB posted a Q2 net loss of $49.258 million, and fiscal 2025 free cash flow was -$321.806 million. Rocket Lab raised $1.53 billion in ATM equity in H1 2026, and Q3 basic shares are guided to 641 million.
Any Neutron slippage or Iridium regulatory hiccup could compress the multiple fast. The dilution funded a $2.129 billion cash war chest and a strategic acquisition that transforms the revenue mix. Our bear-case target lands at $96.31, still above today’s price.
How Rocket Lab Compares to Lockheed Martin and Iridium
Lockheed Martin (NYSE:LMT) is the defense-prime benchmark and a fellow Golden Dome contractor. LMT carries a record $230.42 billion backlog and guided 2026 EPS to $29.95 to $30.65, versus RKLB’s -$0.2682 full-year EPS estimate. LMT trades on cash flow today; RKLB trades on option value. That gap justifies a growth multiple on Rocket Lab.
Iridium Communications (NASDAQ:IRDM) is the recurring-revenue engine RKLB is acquiring. IRDM did $225.24 million in Q2 revenue with 2.63 million subscribers and a market cap near $5 billion. Once folded in, IRDM derisks Rocket Lab’s cash flow profile, making our $123.10 target reasonable rather than aggressive.
Rocket Lab Price Prediction 2026-2030
| Year | 24/7 Wall St. Price Target |
|---|---|
| 2026 | $74 |
| 2027 | $123 |
| 2028 | $204 |
| 2029 | $256 |
| 2030 | $323 |
These projections assume Rocket Lab executes on Neutron, closes Iridium, and continues winning defense contracts. Significant upside or downside could result from Neutron’s inaugural launch outcome.
Our 24/7 Wall St. price target is $123.10 with a buy rating and medium confidence. The tipping factor is the backlog conversion story combined with defense demand.
The setup favors investors who can stomach the volatility and a multi-year hold while Neutron scales. The setup weakens materially if Neutron slips into 2027 or Iridium’s approval drags. On balance, the risk-reward looks compelling.
Contact [email protected] for any questions or corrections.





